Skip to main content
Clinical Trials/NCT03076866
NCT03076866
Unknown
N/A

Suivi Prospectif Des Patients Presentant un Rhumatisme Inflammatoire Chronique

Centre Hospitalier Universitaire de Nice1 site in 1 country1,000 target enrollmentJanuary 1, 2001

Overview

Phase
N/A
Intervention
Not specified
Conditions
Inflammatory Disease
Sponsor
Centre Hospitalier Universitaire de Nice
Enrollment
1000
Locations
1
Primary Endpoint
therapeutic maintenance at 20 years of follow-up
Last Updated
9 years ago

Overview

Brief Summary

It is a prospective follow-up. The aim is to study the maintenance of therapeutic at 10 years and 20 years of inflammatory rheumatism (rheumatoid arthritis and spondyloarthritis)

Detailed Description

All subjects were followed up on a yearly basis collection with clinical data (weight, sex, age, comorbidities, treatment), biological (VS, CRP, ACPA, lipid balance, cross laps), radiology (hand and foot radiographs and ultrasonography ), BMO Measure

Registry
clinicaltrials.gov
Start Date
January 1, 2001
End Date
January 1, 2020
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Service de Rhumatologie

Professor

Centre Hospitalier Universitaire de Nice

Eligibility Criteria

Inclusion Criteria

  • More than 18 years
  • Rheumatoid arthritis meeting ACR criteria Spondyloarthritis meeting ASAS criteria

Exclusion Criteria

  • Patient under guardianship

Outcomes

Primary Outcomes

therapeutic maintenance at 20 years of follow-up

Time Frame: 20 years

All subjects benefit from an annual follow-up including a collection of clinical data (age, sex, weight, comorbidities, swelling and painful joints), biological (CRP, ACPA, cross laps, lipids), radiological, BMO measures (Hologic), and treatments (biological and synthetic DMARDS). Each rheumatologic modification or stop of treatment is transcribed. Therapeutic maintenance definition: modification in rheumatologic treatment (number of DMARDS at 20 years)

Secondary Outcomes

  • evolution of lipidics parameters at 20 years of follow-up(20 years)

Study Sites (1)

Loading locations...

Similar Trials